Available data on the effects of DPP-4i on proBNP-derived peptides in T2D mostly come from large clinical trials wherein NT-proBNP levels were measured years after therapy with a DPP-4i or placebo [19, 20]. This evidence concerns the gene NPPB and type 2 diabetes mellitus.